Clinical trial
Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal…
NCT00324025 · Novartis Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00324025 |
|---|---|
| Title | Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Mycograb® as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cryptococcal Meningitis |
| Intervention type | Drug |
| Interventions | Mycograb, placebo |
| Enrollment | 3 |
| Start date | Mar 1, 2007 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | May 10, 2006 |
| Last update posted | Dec 12, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: